Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr 7;323(13):1251-1252.
doi: 10.1001/jama.2020.0567.

Treatment for Advanced Soft Tissue Sarcoma: An Informative Neutral Trial

Christina L Roland  1 , Sandra L Wong  2   3
Affiliations
Comment

Treatment for Advanced Soft Tissue Sarcoma: An Informative Neutral Trial

Christina L Roland et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Roland reported receiving grants from Bristol-Myers Squibb. No other disclosures were reported.

Comment on

References

    1. Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. IARC Press; 2013.
    1. American Cancer Society. Key statistics for soft tissue sarcomas. Accessed January 20, 2020 https://www.cancer.org/cancer/soft-tissue-sarcoma/about/key-statistics.html
    1. Tap WD, Wagner AJ, Schöffski P, et al.; ANNOUNCE Investigators. Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial. JAMA. Published online: April 7 2020. doi:10.1001/jama.2020.1707 - DOI - PMC - PubMed
    1. Tap WD, Jones RL, Van Tine BA, et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet. 2016;388(10043):488–497 doi:10.1016/S0140-6736(16)30587-6 - DOI - PMC - PubMed
    1. Darrow JJ, Avorn J, Kesselheim AS. FDA approval and regulation of pharmaceuticals, 1983-2018. JAMA. 2020;323(2):164–176. doi:10.1001/jama.2019.20288 - DOI - PubMed